日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Homologous recombination deficiency and hemizygosity drive resistance in breast cancer

同源重组缺陷和半合子状态是乳腺癌耐药性的驱动因素

Safonov, Anton; Lee, Minna; Brown, David N; Boscolo Bielo, Luca; Mehine, Miika; Bandlamudi, Chaitanya; O'Leary, Ben; Shao, Hong; Vicente, Laia; Muldoon, Daniel; Zhu, Allen; Ros, Susana; Marra, Antonio; Selenica, Pier; Bieche, Ivan; Wubbenhorst, Bradley; Ferraro, Emanuela; Courtois, Laura; El Botty, Rania; Ahmed, Mehnaj; Moiso, Enrico; An, Julia Ah-Reum; Donoghue, Mark T A; Will, Marie; Pareja, Fresia; Nizialek, Emily; Lukashchuk, Natalia; Sofianopoulou, Eleni; Liu, Yuan; Huang, Xin; Chappey, Colombe; Staniszewska, Anna D; Ross, Dara; Mandelker, Diana; Ladanyi, Marc; Schultz, Nikolaus; Berger, Michael F; Scaltriti, Maurizio; Reis-Filho, Jorge S; Li, Bob T; Offit, Kenneth; Norton, Larry; Shen, Ronglai; Maxwell, Kara N; Couch, Fergus; Domchek, Susan M; Marangoni, Elisabetta; Shah, Sohrab; Albertella, Mark R; Serra, Violeta; Weigelt, Britta; Solit, David B; Nathanson, Katherine L; Robson, Mark E; Turner, Nicholas C; Chandarlapaty, Sarat; Razavi, Pedram

The Prognostic and Predictive Impact of ctDNA Levels in Patients with Advanced Breast Cancer Enrolled on the plasmaMATCH Trial

plasmaMATCH试验中ctDNA水平对晚期乳腺癌患者的预后和预测影响

Browne, Iseult M; Pascual, Javier; Cutts, Rosalind J; Kingston, Belinda; Hrebien, Sarah; Kilburn, Lucy S; Pearson, Alex; Moretti, Laura; Wardley, Andrew M; Macpherson, Iain R; Baird, Richard D; Roylance, Rebecca; Gil-Gil, Miguel J; Guerrero-Zotano, Ángel L; Garcia-Murillas, Isaac; Bliss, Judith M; Ring, Alistair; Martín, Miguel; Turner, Nicholas C

PI3Kα Inhibitor and Degrader Inavolisib Can Co-opt FGFR2 to Enhance Responses in Patients with PIK3CA-Mutated Solid Tumors and in Preclinical Models.

PI3Kα抑制剂和降解剂Inavolisib可利用FGFR2增强PIK3CA突变实体瘤患者和临床前模型的疗效。

Juric Dejan, Song Kyung, Johnson Radia M, Accordino Melissa K, Bedard Philippe L, Cervantes Andrés, Gambardella Valentina, Hamilton Erika, Italiano Antoine, Kalinsky Kevin, Krop Ian E, Oliveira Mafalda, Saura Cristina, Schmid Peter, Turner Nicholas C, Varga Andreea, Gendreau Steven, Hwang Michael S, Kuang Zheng, Lau Jeffrey T, Lin Eva, Pham Trang, Maddalo Danilo, Rees Matthew G, Ronan Melissa M, Roth Jennifer A, Martin Scott, Sodir Nicole M, Sokol Ethan S, Whitfield Zachary J, Wong Alice, Yauch Robert L, Aimi Junko, Cheeti Sravanthi, Fredrickson Jill, Hilz Stephanie, Hafner Marc, Hutchinson Katherine E, Jin Yanling, Peters Ubong, Zingg Daniel, Royer-Joo Stephanie, Shankar Noopur, Schutzman Jennifer L, Jhaveri Komal L, Dey Anwesha

ctDNA monitoring using tumor-informed copy number analysis

利用肿瘤信息拷贝数分析进行ctDNA监测

Zhou, Ze; Cutts, Ros; Hrebien, Sarah; Zhang, Christina X; Garcia-Murillas, Isaac; Zhang, Woody Z; Frankell, Alexander M; Cooper, Wendy N; Roshan, Amit; Turner, Nicholas C; Kaplan, Tommy; Rosenfeld, Nitzan; Zhao, Hui

Capivasertib plus fulvestrant in patients with HR-positive/HER2-negative advanced breast cancer: phase 3 CAPItello-291 study extended Chinese cohort

Capivasertib联合氟维司群治疗HR阳性/HER2阴性晚期乳腺癌患者:3期CAPItello-291研究扩展中国队列

Hu, Xichun; Zhang, Qingyuan; Sun, Tao; Xiong, Huihua; Li, Wei; Teng, Yuee; Lu, Yen-Shen; Tseng, Ling-Ming; Yan, Min; Li, Hongsheng; Pang, Danmei; -Chen, Shin-Cheh; Chen, Wenyan; Jiang, Ou; Wang, Jingfen; Wu, Xinhong; Wang, Xian; Zang, Aimin; Wang, Xiaojia; Collins, Julie M; Fan, Ethan; Jiang, Lin; Zeng, Xiaoling; Turner, Nicholas C

Longitudinal monitoring of circulating tumor DNA to detect relapse early and predict outcome in early breast cancer

纵向监测循环肿瘤DNA以早期发现复发并预测早期乳腺癌的预后

Garcia-Murillas, Isaac; Cutts, Rosalind J; Walsh-Crestani, Giselle; Phillips, Edward; Hrebien, Sarah; Dunne, Kathryn; Sidhu, Kally; Daber, Robert; Hubert, Benjamin; Graybill, Chiharu; DeFord, Peter M; Wooten, David J; Zhao, Jianhua; Ellsworth, Rachel E; Johnston, Stephen R D; Ring, Alistair; Russell, Simon; Evans, Abigail; Skene, Anthony; Wheatley, Duncan; Smith, Ian E; Korn, W Michael; Turner, Nicholas C

Phase I/Ib Trial of Inavolisib Plus Palbociclib and Endocrine Therapy for PIK3CA-Mutated, Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Advanced or Metastatic Breast Cancer

Inavolisib联合Palbociclib和内分泌疗法治疗PIK3CA突变、激素受体阳性、人表皮生长因子受体2阴性晚期或转移性乳腺癌的I/Ib期临床试验

Jhaveri, Komal L; Accordino, Melissa K; Bedard, Philippe L; Cervantes, Andrés; Gambardella, Valentina; Hamilton, Erika; Italiano, Antoine; Kalinsky, Kevin; Krop, Ian E; Oliveira, Mafalda; Schmid, Peter; Saura, Cristina; Turner, Nicholas C; Varga, Andrea; Cheeti, Sravanthi; Hilz, Stephanie; Hutchinson, Katherine E; Jin, Yanling; Royer-Joo, Stephanie; Peters, Ubong; Shankar, Noopur; Schutzman, Jennifer L; Juric, Dejan

Phase Ia/b Study of Giredestrant ± Palbociclib and ± Luteinizing Hormone-Releasing Hormone Agonists in Estrogen Receptor-Positive, HER2-Negative, Locally Advanced/Metastatic Breast Cancer

Giredestrant ± Palbociclib 和 ± 促黄体生成素释放激素激动剂治疗雌激素受体阳性、HER2 阴性、局部晚期/转移性乳腺癌的 Ia/b 期研究

Jhaveri, Komal L; Bellet, Meritxell; Turner, Nicholas C; Loi, Sherene; Bardia, Aditya; Boni, Valentina; Sohn, Joohyuk; Neilan, Tomas G; Villanueva-Vázquez, Rafael; Kabos, Peter; García-Estévez, Laura; López-Miranda, Elena; Pérez-Fidalgo, J Alejandro; Pérez-García, Jose M; Yu, Jiajie; Fredrickson, Jill; Moore, Heather M; Chang, Ching-Wei; Bond, John W; Eng-Wong, Jennifer; Gates, Mary R; Lim, Elgene

First-Line Ipatasertib, Atezolizumab, and Taxane Triplet for Metastatic Triple-Negative Breast Cancer: Clinical and Biomarker Results

一线伊帕他替尼、阿特珠单抗和紫杉烷三联疗法治疗转移性三阴性乳腺癌:临床和生物标志物结果

Schmid, Peter; Turner, Nicholas C; Barrios, Carlos H; Isakoff, Steven J; Kim, Sung-Bae; Sablin, Marie-Paule; Saji, Shigehira; Savas, Peter; Vidal, Gregory A; Oliveira, Mafalda; O'Shaughnessy, Joyce; Italiano, Antoine; Espinosa, Enrique; Boni, Valentina; White, Shane; Rojas, Beatriz; Freitas-Junior, Ruffo; Chae, Yeesoo; Bondarenko, Igor; Lee, Jieun; Torres Mattos, Cesar; Martinez Rodriguez, Jorge Luis; Lam, Lisa H; Jones, Surai; Reilly, Sarah-Jayne; Huang, Xiayu; Shah, Kalpit; Dent, Rebecca

The Clinical Features and Outcomes of Pseudocirrhosis in Breast Cancer

乳腺癌假性肝硬化的临床特征和预后

Phillips, Edward; Sethi, Mantegh; Vasanthakumar, Surammiya; Sherpa, Gina; Johnston, Stephen; Parton, Marina; Kipps, Emma; Turner, Nicholas C; Foxton, Matthew; Okines, Alicia